Cogstate Limited Logo

Cogstate Limited

COGZF

(1.8)
Stock Price

0,63 USD

12.45% ROA

14.69% ROE

34.45x PER

Market Cap.

161.858.021,00 USD

0.7% DER

0% Yield

13.36% NPM

Cogstate Limited Stock Analysis

Cogstate Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cogstate Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (27.49%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 DER

The stock has a low debt to equity ratio (4%), which means it has a small amount of debt compared to the ownership it holds

4 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (4.77x) suggests it's overvalued, potentially making it an expensive investment.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock appears overvalued (-4) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Cogstate Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cogstate Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Cogstate Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cogstate Limited Revenue
Year Revenue Growth
2003 203.742
2004 134.302 -51.7%
2005 782.147 82.83%
2006 1.540.448 49.23%
2007 1.993.092 22.71%
2008 3.619.834 44.94%
2009 6.770.940 46.54%
2010 8.060.985 16%
2011 8.692.536 7.27%
2012 12.295.486 29.3%
2013 11.373.515 -8.11%
2014 11.547.849 1.51%
2015 12.328.283 6.33%
2016 20.351.327 39.42%
2017 26.850.868 24.21%
2018 28.956.884 7.27%
2019 21.834.374 -32.62%
2020 32.686.396 33.2%
2021 44.980.356 27.33%
2022 40.451.123 -11.2%
2023 62.777.776 35.56%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cogstate Limited Research and Development Expenses
Year Research and Development Expenses Growth
2003 0
2004 28.497 100%
2005 198.484 85.64%
2006 176.089 -12.72%
2007 90.459 -94.66%
2008 144 -63157.34%
2009 161 11.18%
2010 52.075 99.69%
2011 21.368 -143.71%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 999.774 100%
2021 8.613.052 88.39%
2022 10.661.939 19.22%
2023 18.936.832 43.7%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cogstate Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 842.021
2004 1.150.616 26.82%
2005 1.875.396 38.65%
2006 2.307.464 18.72%
2007 2.737.724 15.72%
2008 3.577.592 23.48%
2009 4.309.038 16.97%
2010 4.816.508 10.54%
2011 6.437.171 25.18%
2012 7.305.578 11.89%
2013 6.396.921 -14.2%
2014 7.179.068 10.89%
2015 7.391.186 2.87%
2016 9.273.368 20.3%
2017 12.322.053 24.74%
2018 15.855.198 22.28%
2019 13.697.320 -15.75%
2020 10.260.465 -33.5%
2021 11.798.628 13.04%
2022 14.414.466 18.15%
2023 8.559.468 -68.4%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cogstate Limited EBITDA
Year EBITDA Growth
2003 -816.032
2004 -1.367.220 40.31%
2005 -2.293.371 40.38%
2006 -1.337.240 -71.5%
2007 -1.450.969 7.84%
2008 -827.569 -75.33%
2009 1.267.950 165.27%
2010 739.831 -71.38%
2011 -493.172 250.01%
2012 3.510.577 114.05%
2013 -813.451 531.57%
2014 -3.564.286 77.18%
2015 -1.688.398 -111.1%
2016 1.473.999 214.55%
2017 218.179 -575.59%
2018 832.417 73.79%
2019 -3.271.278 125.45%
2020 8.208.596 139.85%
2021 13.105.056 37.36%
2022 5.689.841 -130.32%
2023 8.102.892 29.78%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cogstate Limited Gross Profit
Year Gross Profit Growth
2003 203.742
2004 134.302 -51.7%
2005 782.147 82.83%
2006 1.348.301 41.99%
2007 1.845.421 26.94%
2008 3.519.106 47.56%
2009 6.285.206 44.01%
2010 6.837.477 8.08%
2011 7.860.168 13.01%
2012 10.941.899 28.16%
2013 6.359.729 -72.05%
2014 5.109.808 -24.46%
2015 6.277.587 18.6%
2016 11.845.274 47%
2017 14.373.183 17.59%
2018 16.256.837 11.59%
2019 10.158.480 -60.03%
2020 17.941.044 43.38%
2021 26.679.692 32.75%
2022 21.587.993 -23.59%
2023 34.993.964 38.31%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cogstate Limited Net Profit
Year Net Profit Growth
2003 -883.887
2004 0 0%
2005 -1.695.907 100%
2006 -1.189.444 -42.58%
2007 -1.402.254 15.18%
2008 -714.207 -96.34%
2009 1.153.787 161.9%
2010 1.391.761 17.1%
2011 -904.395 253.89%
2012 2.509.325 136.04%
2013 -1.786.171 240.49%
2014 -3.660.906 51.21%
2015 -3.882.727 5.71%
2016 1.972.936 296.8%
2017 -633.163 411.6%
2018 -565.918 -11.88%
2019 -2.495.767 77.32%
2020 5.233.283 147.69%
2021 7.519.734 30.41%
2022 3.567.733 -110.77%
2023 10.530.432 66.12%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cogstate Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cogstate Limited Free Cashflow
Year Free Cashflow Growth
2004 -1.624.009
2005 -2.101.738 22.73%
2006 -1.664.321 -26.28%
2007 -1.470.130 -13.21%
2008 -1.061.014 -38.56%
2009 514.887 306.07%
2010 615.865 16.4%
2011 399.645 -54.1%
2012 939.857 57.48%
2013 -1.997.928 147.04%
2014 -4.179.889 52.2%
2015 -3.586.127 -16.56%
2016 1.333.569 368.91%
2017 1.619.561 17.66%
2018 -2.865.370 156.52%
2019 -2.526.959 -13.39%
2020 18.233.613 113.86%
2021 10.525.909 -73.23%
2022 -1.228.349 956.92%
2023 608.769 301.78%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cogstate Limited Operating Cashflow
Year Operating Cashflow Growth
2004 -1.585.329
2005 -2.007.018 21.01%
2006 -1.584.536 -26.66%
2007 -1.353.744 -17.05%
2008 -704.537 -92.15%
2009 914.575 177.03%
2010 1.408.847 35.08%
2011 510.188 -176.14%
2012 1.290.976 60.48%
2013 -1.627.592 179.32%
2014 -3.409.015 52.26%
2015 -2.776.925 -22.76%
2016 2.550.791 208.87%
2017 2.608.352 2.21%
2018 0 0%
2019 -86.920 100%
2020 21.490.177 100.4%
2021 14.087.331 -52.55%
2022 982.109 -1334.4%
2023 673.783 -45.76%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cogstate Limited Capital Expenditure
Year Capital Expenditure Growth
2004 38.680
2005 94.720 59.16%
2006 79.785 -18.72%
2007 116.386 31.45%
2008 356.477 67.35%
2009 399.688 10.81%
2010 792.982 49.6%
2011 110.543 -617.35%
2012 351.119 68.52%
2013 370.336 5.19%
2014 770.874 51.96%
2015 809.202 4.74%
2016 1.217.222 33.52%
2017 988.791 -23.1%
2018 2.865.370 65.49%
2019 2.440.039 -17.43%
2020 3.256.564 25.07%
2021 3.561.422 8.56%
2022 2.210.458 -61.12%
2023 65.014 -3300.02%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cogstate Limited Equity
Year Equity Growth
2003 4.244.612
2004 4.233.073 -0.27%
2005 2.920.714 -44.93%
2006 2.297.425 -27.13%
2007 1.343.259 -71.03%
2008 1.842.050 27.08%
2009 3.983.744 53.76%
2010 5.966.903 33.24%
2011 6.736.561 11.43%
2012 10.461.463 35.61%
2013 8.039.385 -30.13%
2014 12.253.807 34.39%
2015 7.758.163 -57.95%
2016 10.301.778 24.69%
2017 11.066.369 6.91%
2018 11.684.669 5.29%
2019 10.112.577 -15.55%
2020 21.783.337 53.58%
2021 32.922.110 33.83%
2022 37.688.576 12.65%
2023 37.688.576 0%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cogstate Limited Assets
Year Assets Growth
2003 4.438.195
2004 4.390.080 -1.1%
2005 3.347.501 -31.15%
2006 2.828.506 -18.35%
2007 1.999.300 -41.47%
2008 2.657.795 24.78%
2009 5.224.127 49.12%
2010 7.346.523 28.89%
2011 8.398.571 12.53%
2012 12.184.949 31.07%
2013 10.088.091 -20.79%
2014 14.228.833 29.1%
2015 10.972.005 -29.68%
2016 14.658.787 25.15%
2017 16.758.539 12.53%
2018 18.791.705 10.82%
2019 19.239.167 2.33%
2020 51.383.502 62.56%
2021 58.446.594 12.08%
2022 54.066.575 -8.1%
2023 54.066.575 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cogstate Limited Liabilities
Year Liabilities Growth
2003 193.583
2004 157.007 -23.3%
2005 426.787 63.21%
2006 531.081 19.64%
2007 656.042 19.05%
2008 815.745 19.58%
2009 1.240.382 34.23%
2010 1.379.619 10.09%
2011 1.662.010 16.99%
2012 1.723.486 3.57%
2013 2.048.705 15.87%
2014 1.975.026 -3.73%
2015 3.213.842 38.55%
2016 4.357.009 26.24%
2017 5.692.170 23.46%
2018 7.107.036 19.91%
2019 9.126.590 22.13%
2020 29.600.165 69.17%
2021 25.524.484 -15.97%
2022 16.377.999 -55.85%
2023 16.377.999 0%

Cogstate Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.31
Net Income per Share
0.03
Price to Earning Ratio
34.45x
Price To Sales Ratio
2.65x
POCF Ratio
188.75
PFCF Ratio
207.98
Price to Book Ratio
4.89
EV to Sales
2.19
EV Over EBITDA
33.31
EV to Operating CashFlow
136.73
EV to FreeCashFlow
171.47
Earnings Yield
0.03
FreeCashFlow Yield
0
Market Cap
0,16 Bil.
Enterprise Value
0,13 Bil.
Graham Number
0.35
Graham NetNet
0.1

Income Statement Metrics

Net Income per Share
0.03
Income Quality
0.18
ROE
0.11
Return On Assets
0.11
Return On Capital Employed
0.1
Net Income per EBT
1.07
EBT Per Ebit
1.29
Ebit per Revenue
0.1
Effective Tax Rate
-0.07

Margins

Sales, General, & Administrative to Revenue
0.13
Research & Developement to Revenue
0.17
Stock Based Compensation to Revenue
0.04
Gross Profit Margin
0.24
Operating Profit Margin
0.1
Pretax Profit Margin
0.12
Net Profit Margin
0.13

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.01
Free CashFlow per Share
0
Capex to Operating CashFlow
-0.2
Capex to Revenue
-0
Capex to Depreciation
-0.15
Return on Invested Capital
0.07
Return on Tangible Assets
0.12
Days Sales Outstanding
45.7
Days Payables Outstanding
2.28
Days of Inventory on Hand
15.29
Receivables Turnover
7.99
Payables Turnover
160.32
Inventory Turnover
23.88
Capex per Share
-0

Balance Sheet

Cash per Share
0,15
Book Value per Share
0,19
Tangible Book Value per Share
0.14
Shareholders Equity per Share
0.19
Interest Debt per Share
0
Debt to Equity
0.01
Debt to Assets
0
Net Debt to EBITDA
-7.09
Current Ratio
3.19
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
0,02 Bil.
Invested Capital
0.01
Working Capital
0,03 Bil.
Intangibles to Total Assets
0.21
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
625315
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cogstate Limited Dividends
Year Dividends Growth

Cogstate Limited Profile

About Cogstate Limited

Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.

CEO
Mr. Bradley John O'Connor B.Bu
Employee
158
Address
161 Collins Street
Melbourne, 3000

Cogstate Limited Executives & BODs

Cogstate Limited Executives & BODs
# Name Age
1 Ms. Kristi Geddes
General Counsel, Joint Company Secretary & Director
70
2 Ms. Rachel Colite
Executive Vice President of Clinical Trials
70
3 Mr. David James Franks BEc, C.A., F Fin, J.P.
Joint Company Secretary
70
4 Mr. Bradley John O'Connor B.Bus, C.A., CA
Chief Executive Officer, MD & Executive Director
70
5 Prof. Paul Maruff BBSc (Hons), Ph.D.
Founder & Chief Innovation Officer
70
6 Mr. Darren Watson
Chief Financial Officer
70
7 Mr. Benjamin Bloomfield
Chief Technology Officer
70
8 Dr. Chris Edgar Ph.D.
Chief Science Officer
70
9 Mr. Kenneth Billard
Chief Commercial Officer
70

Cogstate Limited Competitors